171 related articles for article (PubMed ID: 32884275)
21. Comparison of Safety Profiles of New Oral Anticoagulants with Warfarin Using the Japanese Spontaneous Reporting Database.
Hosohata K; Oyama S; Niinomi I; Wakabayashi T; Inada A; Iwanaga K
Clin Drug Investig; 2019 Jul; 39(7):665-670. PubMed ID: 31054085
[TBL] [Abstract][Full Text] [Related]
22. Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events.
Mendes D; Alves C; Batel-Marques F
J Clin Pharm Ther; 2014 Jun; 39(3):307-13. PubMed ID: 24635532
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumor Necrosis Factor-Alpha Therapy and Hypoglycemia: A Real-World Pharmacovigilance Analysis.
Zhou Y; Xie W; Wang L; Zhu X; Li J; Liu L; Zhu S; Wang L
Drug Saf; 2022 Sep; 45(9):951-959. PubMed ID: 35857191
[TBL] [Abstract][Full Text] [Related]
24. Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center.
Davidson L; Van den Reek JMPA; Van Hunsel F; De Jong EMGJ; Kullberg BJ
Acta Derm Venereol; 2022 Feb; 102():adv00648. PubMed ID: 35088874
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Time-to-onset and Outcome of Lung Adverse Events With Pomalidomide from a Pharmacovigilance Study.
Kawahara Y; Murata S; Shimizu T; Uesawa Y; Uchida M
In Vivo; 2023; 37(2):955-961. PubMed ID: 36881059
[TBL] [Abstract][Full Text] [Related]
26. Drug-induced hyperglycemia in the Japanese Adverse Drug Event Report database: association of evelolimus use with diabetes.
Konishi H; Shirakawa J; Arai M; Terauchi Y
Endocr J; 2019 Jun; 66(6):571-574. PubMed ID: 30944270
[TBL] [Abstract][Full Text] [Related]
27. Association of Aggression and Antiepileptic Drugs: Analysis Using the Japanese Adverse Drug Event Report (JADER) Database.
Kawada K; Ishida T; Jobu K; Ohta T; Fukuda H; Morisawa S; Kawazoe T; Tamura N; Miyamura M
Biol Pharm Bull; 2022; 45(6):720-723. PubMed ID: 35650100
[TBL] [Abstract][Full Text] [Related]
28. Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System.
Gastaldon C; Raschi E; Kane JM; Barbui C; Schoretsanitis G
Psychother Psychosom; 2021; 90(1):41-48. PubMed ID: 32854103
[TBL] [Abstract][Full Text] [Related]
29. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias.
Pariente A; Gregoire F; Fourrier-Reglat A; Haramburu F; Moore N
Drug Saf; 2007; 30(10):891-8. PubMed ID: 17867726
[TBL] [Abstract][Full Text] [Related]
30. Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database.
Hasegawa S; Ikesue H; Nakao S; Shimada K; Mukai R; Tanaka M; Matsumoto K; Inoue M; Satake R; Yoshida Y; Goto F; Hashida T; Nakamura M
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1279-1294. PubMed ID: 32869941
[TBL] [Abstract][Full Text] [Related]
31. Association of Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs in pediatric patients: Subgroup analysis based on a Japanese spontaneous database.
Inada A; Oyama S; Niinomi I; Wakabayashi T; Iwanaga K; Hosohata K
J Clin Pharm Ther; 2019 Oct; 44(5):775-779. PubMed ID: 31231846
[TBL] [Abstract][Full Text] [Related]
32. Inverse Association between Metformin and Amiodarone-Associated Extracardiac Adverse Events.
Kinoshita S; Hosomi K; Yokoyama S; Takada M
Int J Med Sci; 2020; 17(3):302-309. PubMed ID: 32132864
[No Abstract] [Full Text] [Related]
33. Cardiovascular Adverse Events Associated with Tumor Necrosis Factor-Alpha Inhibitors: A Real-World Pharmacovigilance Analysis.
Ma J; Cai J; Chen H; Feng Z; Yang G
J Atheroscler Thromb; 2024 Jun; ():. PubMed ID: 38866553
[TBL] [Abstract][Full Text] [Related]
34. The Influence of the Rapid Increase in the Number of Adverse Event Reports for COVID-19 Vaccine on the Disproportionality Analysis Using JADER.
Yamaoka K; Fujiwara M; Uchida M; Uesawa Y; Shimizu T
In Vivo; 2023; 37(1):345-356. PubMed ID: 36593055
[TBL] [Abstract][Full Text] [Related]
35. Pharmacovigilance Evaluation of Bendamustine-related Skin Disorders using the Japanese Adverse Drug Event Report Database.
Uchida M; Kawashiri T; Maegawa N; Takano A; Hosohata K; Uesawa Y
J Pharm Pharm Sci; 2021; 24():16-22. PubMed ID: 33440131
[TBL] [Abstract][Full Text] [Related]
36. Lung Cancer Adverse Events Reports for Angiotensin-Converting Enzyme Inhibitors: Data Mining of the FDA Adverse Event Reporting System Database.
Meng L; Yang B; Qiu F; Jia Y; Sun S; Yang J; Huang J
Front Med (Lausanne); 2021; 8():594043. PubMed ID: 33598469
[TBL] [Abstract][Full Text] [Related]
37. Association of gynecomastia with antidiabetic medications in older adults: Data mining from different national pharmacovigilance databases.
Ohyama K; Tanaka H; Shindo J; Shibayama M; Iwata M; Hori Y
Int J Clin Pharmacol Ther; 2022 Jan; 60(1):24-31. PubMed ID: 34622771
[TBL] [Abstract][Full Text] [Related]
38. Disproportionality analysis of stomatitis associated with anticancer drugs using Japanese Adverse Drug Event Reporting Database.
Hosonaka K; Yamaoka K; Ikeda N; Uchida M; Uesawa Y; Takahashi K; Shimizu T
Oncology; 2024 Jan; ():. PubMed ID: 38198784
[TBL] [Abstract][Full Text] [Related]
39. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.
Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M
Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028
[TBL] [Abstract][Full Text] [Related]
40. Subtype-Dependent Reporting of Stroke With SGLT2 Inhibitors: Implications From a Japanese Pharmacovigilance Study.
Sato K; Mano T; Iwata A; Toda T
J Clin Pharmacol; 2020 May; 60(5):629-635. PubMed ID: 31792991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
